FJA update: Glaxo Agrees to Pay $3 Billion in Fraud Settlement
It has been a record year for federal whistleblower recoveries, but is it too little, too late? Are profits coming at the cost of the safety of Americans?
It has been a record year for federal whistleblower recoveries, but is it too little, too late? Are profits coming at the cost of the safety of Americans?
deceptive trade practices, plaintiff lawyers, pharmaceutical giants, pharmaceutical industry, law firms, drug marketing, prescription drugs, whistle blower, antidepressant drugs,
It has been a record year for federal whistleblower recoveries, but is it too little, too late? Are profits coming at the cost of the safety of Americans?
deceptive trade practices, plaintiff lawyers, pharmaceutical giants, pharmaceutical industry, law firms, drug marketing, prescription drugs, whistle blower, antidepressant drugs,